Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-13

Clinical Trial Update: Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors

View source ↗

Summary

This entry reports the completion of a clinical trial cohort studying well-differentiated grade 3 neuroendocrine tumors of the digestive tract.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Neuroendocrine Tumors | Status: COMPLETED